Skip to main content
Roger Albin, MD, Neurology, Ann Arbor, MI

Roger L Albin MD

Movement Disorder


Professor of neurology, associate chair for research and co-director of the Movement Disorders Clinic in the Department of Neurology in the University of Michigan Medical School; Chief of neuroscience research at the VA Ann Arbor Healthcare System Geriatric Research Education and Clinical Center.

Join to View Full Profile
  • 4260 Plymouth RoadAnn Arbor, MI 48109

  • Phone+1 734-647-5650

Dr. Albin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Michigan
    University of MichiganResidency, Neurology, 1983 - 1988
  • University of Michigan
    University of MichiganInternship, Internal Medicine, 1982 - 1983
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 1982

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1984 - 2027
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Human Brainome: Network Analysis Identifies HSPA2 as a Novel Alzheimer’s Disease Target  
    Christine M Hulette, David A Bennett, Roger L Albin, Thomas G Beach, Randall L Woltjer, Andrew P Lieberman, John F Ervin, Anzhelika Engel, Julie A Schneider, Rui Chang, Brain
  • Quantification of Brain Cholinergic Denervation in Dementia with Lewy Bodies Using PET Imaging with [18F]-FEOBV  
    Kirk A Frey, Roger L Albin, Nicolaas I Bohnen, Nature

Press Mentions

  • Clinical Trials That Will Shape Medicine in 2023
    Clinical Trials That Will Shape Medicine in 2023February 2nd, 2023
  • Brains in the Balance: New $11.5M Grant Fuels U-M Parkinson’s Disease Research Center to Aid Patients
    Brains in the Balance: New $11.5M Grant Fuels U-M Parkinson’s Disease Research Center to Aid PatientsFebruary 12th, 2016
  • Midlife Blood Test May Predict Cognitive Decline, Alzheimer’s in Later Life
    Midlife Blood Test May Predict Cognitive Decline, Alzheimer’s in Later LifeDecember 23rd, 2023
  • Join now to see all

Grant Support

  • UM Clinical Neuroscientist Training ProgramUNIVERSITY OF MICHIGAN AT ANN ARBOR2014–2029
  • Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson DiseaseUNIVERSITY OF MICHIGAN AT ANN ARBOR2021–2026
  • Reducing falls with Varenicline in Hypocholinergic Parkinson diseaseUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2025
  • NR2B Mediated Neurotoxicity In Murine Huntington Disease ModelVeterans Affairs2011
  • Serotonin And Sleep Disordered Breathing In Parkinson DiseaseNational Institute Of Neurological Disorders And Stroke2008–2011
  • Neurodegeneration In Aging Retarded MiceNational Institute Of Neurological Disorders And Stroke2008–2009
  • Differentiating Degenerative Dementia With [11c]Dtbz-Pet ImagingNational Institute On Aging2005–2009
  • Evaluating Striatal Function In A Murine HD ModelNational Institute Of Neurological Disorders And Stroke2006–2007
  • Dopamine Synaptic Mechanisms In Tourette SyndromeNational Center For Research Resources2005–2007
  • Michigan Parkinson'S Disease Clinical CenterNational Institute Of Neurological Disorders And Stroke2002–2007
  • COQ10 And GPI 1485 In Subjects With Early Untreated Parkinson'SNational Center For Research Resources2005–2006
  • Minocycline &Creatine In Subjects W/ Early Untreated Parkinson?S DiseaseNational Center For Research Resources2005
  • Minocycline &Creatine In Subjects W/ Early Untreated Parkinson'S DiseaseNational Center For Research Resources2004
  • Dopamine Synaptic Mechanisms In Tourette'S SyndromeNational Institute Of Neurological Disorders And Stroke2001–2002
  • Murine Model Of CAG Repeat DiseasesNational Institute Of Neurological Disorders And Stroke1999–2002
  • PET Studies Of Hyperkinetic Movement DisordersNational Institute Of Neurological Disorders And Stroke1996–1999
  • Chronic Striatal QuinolinateNational Institute On Aging1996–1998
  • PET Studies In Tourette'S SyndromeNational Center For Research Resources1996
  • Huntington Disease And Quinolinate--Striatal Cell TypesNational Institute Of Neurological Disorders And Stroke1988–1992

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: